|  Help  |  About  |  Contact Us

Search our database by keyword

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 1101 to 1156 out of 1156 for Mapk8

<< First    < Previous  |  Next >    Last >>
0.029s

Categories

Hits by Pathway

Hits by Category

Hits by Strain

Type Details Score
UniProt Feature
UniProt Feature
Begin: 232
Description: Phosphoserine; by MAPK8
Type: modified residue
End: 232
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 120
Description: Phosphoserine; by MAPK8
Type: modified residue
End: 120
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 148
Description: Phosphothreonine; by MAPK8
Type: modified residue
End: 148
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 183
Description: Phosphothreonine; by MAPK8
Type: modified residue
End: 183
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 135
Description: Phosphoserine; by MAPK8
Type: modified residue
End: 135
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 706
Description: Phosphothreonine; by MAPK8
Type: modified residue
End: 706
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 696
Description: Phosphoserine; by MAPK8
Type: modified residue
End: 696
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 46
Description: Phosphoserine; by MAPK8
Type: modified residue
End: 46
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 280
Description: Phosphothreonine; by MAPK8
Type: modified residue
End: 280
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 384
Description: Phosphoserine; by MAPK1 and MAPK8
Type: modified residue
End: 384
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 213
Description: Phosphoserine; by MAPK8 and MAPK9
Type: modified residue
End: 213
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 217
Description: Phosphoserine; by MAPK8 and MAPK9
Type: modified residue
End: 217
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 73
Description: Phosphoserine; by MAPK8 and PLK3
Type: modified residue
End: 73
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 308
Description: Phosphoserine; by MAPK8 and MAPK9
Type: modified residue
End: 308
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 70
Description: Phosphoserine; by MAPK8 and PKC
Type: modified residue
End: 70
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 265
Description: Phosphoserine; by MAPK8 and MAPK9
Type: modified residue
End: 265
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 87
Description: Phosphothreonine; by MAPK8 and MAPK9
Type: modified residue
End: 87
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 75
Description: Phosphoserine; by MAPK8 and MAPK9
Type: modified residue
End: 75
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 61
Description: Phosphoserine; by MAPK8 and MAPK9
Type: modified residue
End: 61
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 347
Description: Phosphoserine; by MAPK8 and MAPK9
Type: modified residue
End: 347
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 863
Description: Phosphoserine; by MAPK8 and MTOR
Type: modified residue
End: 863
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 397
Description: Phosphothreonine; by MAPK8 and MAPK9
Type: modified residue
End: 397
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 352
Description: Phosphoserine; by MAPK8 and MAPK9
Type: modified residue
End: 352
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 104
Description: Phosphothreonine; by MAPK8 and MAPK9
Type: modified residue
End: 104
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 307
Description: Phosphoserine; by IKKB, MAPK8 and RPS6KB1
Type: modified residue
End: 307
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 522
Description: Phosphothreonine; by DYRK1A, DYRK3 and MAPK8
Type: modified residue
End: 522
•
•
•
•
•
UniProt Feature
UniProt Feature
Begin: 738
Description: Phosphothreonine; by MAPK1, MAPK3 and MAPK8
Type: modified residue
End: 738
•
•
•
•
•
Allele
Mapk8<em1Smoc> | MGI:7290970
Name: mitogen-activated protein kinase 8; endonuclease-mediated mutation 1, Shanghai Model Organisms Center
Allele Type: Endonuclease-mediated
Attribute String: Null/knockout
•
•
•
•
•
Strain
MGI:6429152 | C57BL/6JSmoc-Mapk8<em1Smoc>/Smoc
Attribute String: coisogenic, mutant strain, endonuclease-mediated mutation
•
•
•
•
•
GO Term
GO:0007254 | JNK cascade
•
•
•
•
•
Allele
Gt(ROSA)26Sor<tm17(MAP2K7/MAPK8)Jhai> | MGI:5575397
Name: gene trap ROSA 26, Philippe Soriano; targeted mutation 17, Jody Haigh
Allele Type: Targeted
Attribute String: Conditional ready, Humanized sequence, Inserted expressed sequence, Reporter
•
•
•
•
•
Allele
Tg(Mapk8-EGFP)FV33Gsat | MGI:4847220
Name: transgene insertion FV33, GENSAT Project at Rockefeller University
Allele Type: Transgenic
Attribute String: Reporter
•
•
•
•
•
Protein
Q8BVZ5
Organism: Mus musculus/domesticus
Length: 266  
Fragment?: false
•
•
•
•
•
Protein
H3BKB5
Organism: Mus musculus/domesticus
Length: 83  
Fragment?: true
•
•
•
•
•
Protein
D3Z6T7
Organism: Mus musculus/domesticus
Length: 66  
Fragment?: true
•
•
•
•
•
Protein
E9M2E8
Organism: Mus musculus/domesticus
Length: 166  
Fragment?: true
•
•
•
•
•
Protein
H3BLN5
Organism: Mus musculus/domesticus
Length: 228  
Fragment?: true
•
•
•
•
•
Publication
17185418 | -
First Author: Carriere V
Year: 2007
Journal: Proc Natl Acad Sci U S A
Title: IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.
Volume: 104
Issue: 1
Pages: 282-7
•
•
•
•
•
Publication
22215666 | -
First Author: Kakkar R
Year: 2012
Journal: J Biol Chem
Title: Interleukin 33 as a mechanically responsive cytokine secreted by living cells.
Volume: 287
Issue: 9
Pages: 6941-8
•
•
•
•
•
Protein Domain
IPR026145 | IL-33
Type: Family
Description: This entry represents interleukin-33 (IL33), which that binds to and signals through IL1RL1/ST2 and its stimulation recruits MYD88, IRAK1, IRAK4, and TRAF6, followed by phosphorylation of MAPK3/ERK1 and/or MAPK1/ERK2, MAPK14, and MAPK8 [, ]. It also serves as a warning signal between cells at times of injury or cell death [].
•
•
•
•
•
Strain
MGI:5003652 | STOCK Tg(Mapk8-EGFP)FV33Gsat/Mmucd
Attribute String: mutant stock, transgenic
•
•
•
•
•
Allele
Gt(ROSA)26Sor<tm1(CAG-MAP2K7*/MAPK8,-EGFP)Ftw> | MGI:5494696
Name: gene trap ROSA 26, Philippe Soriano; targeted mutation 1, F Thomas Wunderlich
Allele Type: Targeted
Attribute String: Conditional ready, Constitutively active, Humanized sequence, Inserted expressed sequence, Reporter
•
•
•
•
•
Publication
31533924 | J:284125
 
First Author: Qin Y
Year: 2019
Journal: Development
Title: WDR62 is involved in spindle assembly by interacting with CEP170 in spermatogenesis.
Volume: 146
Issue: 20
•
•
•
•
•
Protein Domain
IPR038498 | OspF/SpvC_sf
Type: Homologous_superfamily
Description: This entry includes the virulence protein SpvC and the phosphothreonine lyase OspF. OspF catalyses the removal of the phosphate group from the phosphothreonine in the mitogen-activated protein kinases such as MAPK2/ERK2, MAPK3/ERK1, MAPK8 and MAPK14 in an irreversible reaction, thus preventing the downstream phosphorylation of histone H3. This epigenetic modification results in inhibition of the transcription of a specific subset of proinflammatory genes, and ultimately to a reduced immune response against the invading pathogen. The diminished immune response enhances the bacterium's ability to disseminate and multiply within the host [, , ].The spv region of the Salmonella virulence plasmids consists of five genes located on an 8-kb fragment, shown to be essential for virulence in mice []. SpvC (also known as mkfA and VirA []) is part of this gene cluster and is utilised by the microbe upon entry into macrophages, although the exact mechanism is unclear.
•
•
•
•
•
Protein Domain
IPR003519 | OspF/SpvC
Type: Family
Description: This entry includes the virulence protein SpvC and the phosphothreonine lyase OspF. OspF catalyses the removal of the phosphate group from the phosphothreonine in the mitogen-activated protein kinases such as MAPK2/ERK2, MAPK3/ERK1, MAPK8 and MAPK14 in an irreversible reaction, thus preventing the downstream phosphorylation of histone H3. This epigenetic modification results in inhibition of the transcription of a specific subset of proinflammatory genes, and ultimately to a reduced immune response against the invading pathogen. The diminished immune response enhances the bacterium's ability to disseminate and multiply within the host [, , ].The spv region of the Salmonella virulence plasmids consists of five genes located on an 8-kb fragment, shown to be essential for virulence in mice []. SpvC (also known as mkfA and VirA []) is part of this gene cluster and is utilised by the microbe upon entry into macrophages, although the exact mechanism is unclear.
•
•
•
•
•
Genotype
Genotype
Symbol: Gt(ROSA)26Sor/Gt(ROSA)26Sor<+> Tg(Ckmm-cre)5Khn/?
Background: involves: C57BL/6 * FVB
Zygosity: cn
Has Mutant Allele: true
•
•
•
•
•
Publication
17159983 | -
First Author: Arbibe L
Year: 2007
Journal: Nat Immunol
Title: An injected bacterial effector targets chromatin access for transcription factor NF-kappaB to alter transcription of host genes involved in immune responses.
Volume: 8
Issue: 1
Pages: 47-56
•
•
•
•
•
Publication
17305427 | -
First Author: Kramer RW
Year: 2007
Journal: PLoS Pathog
Title: Yeast functional genomic screens lead to identification of a role for a bacterial effector in innate immunity regulation.
Volume: 3
Issue: 2
Pages: e21
•
•
•
•
•
Publication
17303758 | -
First Author: Li H
Year: 2007
Journal: Science
Title: The phosphothreonine lyase activity of a bacterial type III effector family.
Volume: 315
Issue: 5814
Pages: 1000-3
•
•
•
•
•
Publication
1400193 | -
First Author: Roudier C
Year: 1992
Journal: J Bacteriol
Title: Characterization of translation termination mutations in the spv operon of the Salmonella virulence plasmid pSDL2.
Volume: 174
Issue: 20
Pages: 6418-23
•
•
•
•
•
Publication
1378053 | -
First Author: Krause M
Year: 1992
Journal: J Bacteriol
Title: Regulation of plasmid virulence gene expression in Salmonella dublin involves an unusual operon structure.
Volume: 174
Issue: 13
Pages: 4482-9
•
•
•
•
•
Publication
29749399 | J:269488
     
First Author: Heaton WL
Year: 2018
Journal: Leukemia
Title: Autocrine Tnf signaling favors malignant cells in myelofibrosis in a Tnfr2-dependent fashion.
•
•
•
•
•
Publication
15254788 | J:96648
First Author: Katoh M
Year: 2004
Journal: Int J Mol Med
Title: Identification and characterization of ARHGAP24 and ARHGAP25 genes in silico.
Volume: 14
Issue: 2
Pages: 333-8
•
•
•
•
•
Publication
28218919 | J:251277
First Author: Wang PX
Year: 2017
Journal: Nat Med
Title: Targeting CASP8 and FADD-like apoptosis regulator ameliorates nonalcoholic steatohepatitis in mice and nonhuman primates.
Volume: 23
Issue: 4
Pages: 439-449
•
•
•
•
•
Publication
29106399 | J:252611
First Author: Awazawa M
Year: 2017
Journal: Nat Med
Title: A microRNA screen reveals that elevated hepatic ectodysplasin A expression contributes to obesity-induced insulin resistance in skeletal muscle.
Volume: 23
Issue: 12
Pages: 1466-1473
•
•
•
•
•
Publication
- | J:100256
     
First Author: The Gene Expression Nervous System Atlas (GENSAT) Project, The Rockefeller University (New York, NY)
Year: 2005
Journal: Database Download
Title: MGI download of GENSAT transgene data
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom